Edges in Network
| Network | GSE25055_egf1520 - GSE25055 - SiGN-BN HC+Bootstrap |
| Network Description | Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | EIF2AK2 |
| Upstream (Parents) |
|---|
| (<<) ADCY3 → EIF2AK2 |
| (<<) ALDOA → EIF2AK2 |
| (<<) ALOX15B → EIF2AK2 |
| (<<) CAPRIN2 → EIF2AK2 |
| (<<) CEND1 → EIF2AK2 |
| (<<) DHRS9 → EIF2AK2 |
| (<<) GLS → EIF2AK2 |
| (<<) GSTM3 → EIF2AK2 |
| (<<) HLA-A → EIF2AK2 |
| (<<) HLA-F → EIF2AK2 |
| (<<) ICAM2 → EIF2AK2 |
| (<<) IGFBP3 → EIF2AK2 |
| (<<) ITGA5 → EIF2AK2 |
| (<<) JUND → EIF2AK2 |
| (<<) LDLR → EIF2AK2 |
| (<<) MT1P2 → EIF2AK2 |
| (<<) MYL3 → EIF2AK2 |
| (<<) PCK2 → EIF2AK2 |
| (<<) PLAT → EIF2AK2 |
| (<<) PNO1 → EIF2AK2 |
| (<<) PRKCG → EIF2AK2 |
| (<<) RASSF1 → EIF2AK2 |
| (<<) RNASE4 → EIF2AK2 |
| (<<) RPS6KA5 → EIF2AK2 |
| (<<) RTN3 → EIF2AK2 |
| (<<) SOX9 → EIF2AK2 |
| (<<) SP3 → EIF2AK2 |
| (<<) SPAG5 → EIF2AK2 |
| (<<) SPATA2L → EIF2AK2 |
| (<<) SPDEF → EIF2AK2 |
| (<<) STAT1 → EIF2AK2 |
| (<<) THY1 → EIF2AK2 |
| (<<) UBE2C → EIF2AK2 |
| (<<) UBE2J1 → EIF2AK2 |
| (<<) UBE2L6 → EIF2AK2 |
| (<<) UGDH → EIF2AK2 |
| (<<) VAV3 → EIF2AK2 |
| (<<) WBP4 → EIF2AK2 |
| (<<) YWHAH → EIF2AK2 |
| Downstream (Children) |
|---|
| EIF2AK2 → ASB1 (>>) |
| EIF2AK2 → CDH22 (>>) |
| EIF2AK2 → EPHB2 (>>) |
| EIF2AK2 → GRB10 (>>) |
| EIF2AK2 → HCN4 (>>) |
| EIF2AK2 → HK2 (>>) |
| EIF2AK2 → ITGB1 (>>) |
| EIF2AK2 → MYO1E (>>) |
| EIF2AK2 → NPAS3 (>>) |
| EIF2AK2 → PLA2R1 (>>) |
| EIF2AK2 → PLCG1 (>>) |
| EIF2AK2 → PTEN (>>) |
| EIF2AK2 → RPS6KA2 (>>) |
| EIF2AK2 → SPRR3 (>>) |
| EIF2AK2 → T (>>) |
| EIF2AK2 → UBE2I (>>) |
